GLEEVEC vs SCEMBLIX

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. GLEEVEC and SCEMBLIX are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	GLEEVEC	SCEMBLIX
Rating	70/100	70/100
Pharmacy pays	~$25.80 /30	—
Type	RX	RX
Active ingredient	IMATINIB MESYLATE	ASCIMINIB HYDROCHLORIDE
Manufacturer	Novartis	Novartis
Dosage forms	Tablet	Tablet
Drug class	Kinase Inhibitor	—
Boxed warning	None	None
Treats	Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome	Myeloid Leukemia

gleevec scemblix

Rating

70/100

Pharmacy pays

~$25.80 /30

—

Type

Active ingredient

IMATINIB MESYLATE

ASCIMINIB HYDROCHLORIDE

Manufacturer

Novartis

Dosage forms

Tablet

Drug class

Kinase Inhibitor

—

Boxed warning

None

Treats

Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome

Myeloid Leukemia

Frequently asked questions

Which is better-rated, Gleevec or Scemblix?

Gleevec and Scemblix are tied at 3.5 out of 5 by our independent rating.

What is the difference between Gleevec and Scemblix?

Gleevec contains Imatinib Mesylate, while Scemblix contains Asciminib Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.